COYA8:00 AMCoya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Updatecoyatherapeutics.com
COYA8:00 AMCoya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meetingcoyatherapeutics.com
COYA8:00 AMCoya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Diseasecoyatherapeutics.com
COYA8:00 AMCoya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension PhaseTrial Start • Phase 2coyatherapeutics.com